| Final version of 2009 AJCC melanoma staging and classification CM Balch, JE Gershenwald, S Soong, JF Thompson, MB Atkins, DR Byrd, ... Journal of clinical oncology 27 (36), 6199, 2009 | 5552 | 2009 |
| The histogenesis and biologic behavior of primary human malignant melanomas of the skin WH Clark Jr, L From, EA Bernardino, MC Mihm Cancer research 29 (3), 705-727, 1969 | 3188 | 1969 |
| Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017 | 2118 | 2017 |
| Melanoma AJ Miller, MC Mihm Jr New England Journal of Medicine 355 (1), 51-65, 2006 | 2021 | 2006 |
| Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma CG Clemente, MC Mihm Jr, R Bufalino, S Zurrida, P Collini, N Cascinelli Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 1498 | 1996 |
| Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients FS Hodi, MC Mihm, RJ Soiffer, FG Haluska, M Butler, MV Seiden, T Davis, ... Proceedings of the National Academy of sciences 100 (8), 4712-4717, 2003 | 1202 | 2003 |
| Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response S Monti, KJ Savage, JL Kutok, F Feuerhake, P Kurtin, M Mihm, B Wu, ... Blood 105 (5), 1851-1861, 2005 | 974 | 2005 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10, 1-10, 2012 | 951 | 2012 |
| GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas PE North, M Waner, A Mizeracki, MC Mihm Jr Human pathology 31 (1), 11-22, 2000 | 943 | 2000 |
| Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma CG Lian, Y Xu, C Ceol, F Wu, A Larson, K Dresser, W Xu, L Tan, Y Hu, ... Cell 150 (6), 1135-1146, 2012 | 856 | 2012 |
| Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients FS Hodi, M Butler, DA Oble, MV Seiden, FG Haluska, A Kruse, S MacRae, ... Proceedings of the National Academy of Sciences 105 (8), 3005-3010, 2008 | 817 | 2008 |
| Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger CM Balch, SJ Soong, AA Bartolucci, MM Urist, CP Karakousis, TJ Smith, ... Annals of surgery 224 (3), 255-266, 1996 | 816 | 1996 |
| Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm) results of a multi-institutional randomized surgical trial CM Balch, MM Urist, CP Karakousis, TJ Smith, WJ Temple, K Drzewiecki, ... Annals of surgery 218 (3), 262-269, 1993 | 745 | 1993 |
| Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in … R Soiffer, T Lynch, M Mihm, K Jung, C Rhuda, JC Schmollinger, FS Hodi, ... Proceedings of the National Academy of Sciences 95 (22), 13141-13146, 1998 | 730 | 1998 |
| Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, ... Cell 162 (6), 1242-1256, 2015 | 662 | 2015 |
| Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study NP Sanchez, MA Pathak, S Sato, TB Fitzpatrick, JL Sanchez, MC Mihm Jr Journal of the American Academy of Dermatology 4 (6), 698-710, 1981 | 662 | 1981 |
| Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival SS Dadras, T Paul, J Bertoncini, LF Brown, A Muzikansky, DG Jackson, ... The American journal of pathology 162 (6), 1951-1960, 2003 | 626 | 2003 |
| A unique microvascular phenotype shared by juvenile hemangiomas and human placenta PE North, M Waner, A Mizeracki, RE Mrak, R Nicholas, J Kincannon, ... Archives of dermatology 137 (5), 559-570, 2001 | 616 | 2001 |
| Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm) CM Balch, S Soong, MI Ross, MM Urist, CP Karakousis, WJ Temple, ... Annals of surgical oncology 7 (2), 87-97, 2000 | 606 | 2000 |
| Bevacizumab plus ipilimumab in patients with metastatic melanoma FS Hodi, D Lawrence, C Lezcano, X Wu, J Zhou, T Sasada, W Zeng, ... Cancer immunology research 2 (7), 632-642, 2014 | 563 | 2014 |
